Norsik: Will not independently develop innovative drugs, may acquire CRO companies in the future.

Norsdex stated on the Shenzhen Stock Exchange interactive platform that the company will not independently develop innovative drugs, and may in the future acquire CRO companies related to clinical trials. In addition, the company mentioned that it collaborates with most of the top 20 pharmaceutical companies worldwide.